Why a Melanoma Vaccine Breakthrough Matters for Synovial Sarcoma
Merck and Moderna are making headlines after their personalized mRNA cancer vaccine entered Phase 3 clinical trials for melanoma. For most people, it is an exciting medical story. For the synovial sarcoma community, it is something more personal than that. What the Vaccine Is mRNA-4157,…
A new preclinical study published in Biomedicine and Pharmacotherapy by Tomohiro Miyazaki, Yudai Murayama, Naoki Oike, and colleagues from the Department of Pediatrics and Division of Orthopedic Surgery at Niigata University Graduate School of Medical and Dental Sciences, Japan, presents early but promising evidence for…
Kaela Graham-Bowman’s story reached national audiences this year when she was featured on 60 Minutes Australia. An Afghanistan veteran and nurse, Kaela was diagnosed with synovial sarcoma in 2020 at age 28, while working as an oncology nurse herself. What followed was a six-year fight…
Synovial Sarcoma Foundation Announces Formation of Medical Advisory Board
11 Leading Oncologists and Researchers Unite to Accelerate Progress for Synovial Sarcoma Patients PHILADELPHIA [June 22, 2026] The Synovial Sarcoma…
Breaking Down Synovial Sarcoma’s Defenses: A study on Immune Evasion and Targeted Treatment
A landmark study from Jerby-Arnon, Neftel, Shore, and colleagues at the Broad Institute of Harvard and MIT, Massachusetts General Hospital,…
When Synovial Sarcoma Hides in Plain Sight: A Diagnostic Wake-Up Call
A case report published in Frontiers in Oncology by Miyazaki, Oike, and colleagues at Niigata University Graduate School of Medical…
Rare Synovial Sarcoma Cases Highlight New Limb-Sparing Reconstruction Approach
A new case report published in the World Journal of Surgical Oncology explored an innovative reconstruction technique for rare soft…
Research Highlights Importance of Patient-Centered Sarcoma Surveillance
A 2022 study explored how sarcoma patients feel about long-term surveillance imaging after treatment, highlighting the emotional, financial, and practical…
Study Finds Tumor Size and Surgical Margins are Key Drivers of Synovial Sarcoma Outcomes
A new multi-center retrospective study from three major U.S. sarcoma centers has analyzed outcomes in patients with localized synovial sarcoma,…
North America Synovial Sarcoma Treatment Market Expected to Grow Through 2033
New industry analyses project continued growth in the North America synovial sarcoma treatment market, with a predicted compound annual growth…
Rare Cranial Synovial Sarcoma Case Highlights Importance of Accurate Diagnosis
Synovial sarcoma is a rare and aggressive soft tissue cancer that most often develops near the joints of the arms…
Synovial Sarcoma Foundation Wins First Place at the 16th Annual SPAGN Conference
We are incredibly honored to share that the Synovial Sarcoma Foundation received First Place in the Advocacy in Action Award…
